Wall Street Rallies Behind Lexeo Therapeutics (LXEO)’s Gene Therapy Pipeline

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, Lexeo Therapeutics, Inc. (NASDAQ:LXEO) is a consensus buy from all eleven analysts covering the stock. While the target price ranges from $12 to$ 30, the median price target of $19 translates to an upside potential of 79.92%. On December 18, Raymond James initiated coverage on Lexeo Therapeutics, Inc. (NASDAQ:LXEO) with a ‘Strong Buy’ rating and a price target of$ 25, citing solid results fr ...